logo

AstraZeneca Pharmaceutical Substance Manufacturing Facility

Sector: Manufacturing (Industrial) • Location: Charlottesville, Virginia, United States

Source: Manufacturing Dive

Project
Planned

AstraZeneca is investing $4 billion to build a facility in Charlottesville, Virginia, to manufacture medications for chronic diseases and antibody-drug conjugates. The project is supported by the Pharmaceutical Substance Manufacturing Grant Fund with grant installments up to $34 million per fiscal year from July 1, 2026, to July 1, 2045.

Status
Prospective
Sector
Manufacturing (Industrial)
Location
Charlottesville, Virginia, United States of America
Updated
22 Jul 2026
Source
Manufacturing Dive

ConstructChat

Ask ConstructChat about AstraZeneca Pharmaceutical Substance Manufacturing Facility

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “AstraZeneca Pharmaceutical Substance Manufacturing Facility” is an infrastructure initiative in the Manufacturing (Industrial) sector, located in Charlottesville, Virginia, United States. Taiyo aggregates data on it from Manufacturing Dive.

Participants

Not available for this record.

Status

Original status

planned

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

AstraZeneca is investing $4 billion to build a facility in Charlottesville, Virginia, to manufacture medications for chronic diseases and antibody-drug conjugates. The project is supported by the Pharmaceutical Substance Manufacturing Grant Fund with grant installments up to $34 million per fiscal year from July 1, 2026, to July 1, 2045.

Original sector

Manufacturing

Budget

Location

Country

United States of America (USA)

State

Virginia

City

Charlottesville

Source

Source

Manufacturing Dive

URL

More Details

Record type

Project

Sector

Manufacturing (Industrial)

Article published date

2026-04-11

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project